Install
Breast & Gyn Cancers
Screening, genetics, surgical/medical treatment, and survivorship supports.
- 3 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Breast & Gyn Cancers
AI Tool Outperforms PD-L1 for Predicting Lung Cancer Immunotherapy Outcomes
4+ hour, 35+ min ago (253+ words) One of the study’s most notable findings was that relatively simple information already routinely collected in clinical practice carried substantial predictive power. Models using clinical and blood data, including PD-L1 expression, ECOG performance status, smoking status, metastatic sites, neutrophil-to-lymphocyte ratio,…...
Biofrontera Wins FDA Approval for Ameluz in Superficial Basal Cell Carcinoma
6+ hour, 23+ min ago (296+ words) Minichart We value your privacy No cookies to display. Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features. Advertisement cookies are used to provide visitors with…...
Newsmakers: Michelle Perdue's One-Woman Show Takes Aim at Breast Cancer
3+ hour, 15+ min ago (248+ words) For Michelle Perdue, Jan. 17, 2017, was the day that changed her life. It was the day she learned she had breast cancer. Fast forward to today, she has not only survived but thrived. Perdue is the writer and sole actor in…...
Abbott Agrees to Pay $385 Million to Resolve Contaminated Infant Formula Claims | Forth
1+ hour, 41+ min ago (410+ words) Abbott Laboratories agreed to pay $384,999,040 to settle False Claims Act allegations that it knowingly manufactured infant formula in unsafe conditions and sold it to federal and state programs, according to a DOJ announcement on Sept 14, 2026 [thread#01a0a108-b964-788e-b7bf-cfaf586fbd7a] The settlement covers $348,700,868 to…...
Causal multi-modal AI predicts who benefits from chemotherapy — and who will not
5+ hour, 39+ min ago (510+ words) Authors: Dhruva Biswas and Krzysztof J. Geras AI-enabled perception of how treatment choice shapes patient trajectories. Causal multi-modal AI turns routine pathology and clinical data into personalized estimates of chemosensitivity, separating risk of recurrence from treatment benefit to help direct chemotherapy…...
ZNTL: Azenosertib nears pivotal data in ovarian cancer, with FDA backing and robust financial runway
1+ hour, 9+ min ago (77+ words) TradingView Azenosertib is advancing in late-stage trials for platinum-resistant ovarian cancer, with strong FDA support and a differentiated safety profile. Expansion into earlier lines and other tumor types is under evaluation, while commercial and financial preparations ensure readiness for upcoming…...
Ataraxis AI Publishes Landmark Studies Showing Causal AI Predicts Chemotherapy Benefit in Multiple Solid Tumors
13+ hour, 59+ min ago (324+ words) NEW YORK, September 14, 2026--(BUSINESS WIRE)--Ataraxis AI, a company building clinical AI tools to personalize cancer care, today announced scientific breakthroughs and validation results of Ataraxis's AI models. Ataraxis developed breakthrough causal AI methods that learn from large-scale, longitudinal data…...
Why Katherine LaNasa Was 'Stunned' Walking on Set at 'The Pitt' After Breast Cancer Treatment
2+ hour, 13+ min ago (346+ words) Katherine LaNasa is taking her real-life medical journey and channeling it directly into her work. The 59-year-old actress plays charge nurse Dana Evans on the HBO Max medical drama The Pitt, a role that recently earned her an Emmy in…...
Veteran actress Nafisa Ali reveals her Stage 4 ovarian cancer has spread to liver, says 'I have been put on Targeted Therapy"
12+ hour, 19+ min ago (371+ words) Veteran actress Nafisa Ali has shared an update on her health. The actress revealed that her treatment plan has changed due to the progression of her ovarian/peritoneal cancer. The latest update came after Nafisa Ali revealed her ovarian cancer…...
Race to End Women’s Cancer Returns to D.C. as Gynecologic Cancer Cases Continue to Rise
15+ hour, 59+ min ago (259+ words) Amid rising uterine cancer cases and the critical need to address all women's cancers, the annual event unites survivors, families, and advocates for a free educational forum and community Race weekend WASHINGTON, Sept. 14, 2026 (GLOBE NEWSWIRE) -- (Feature Impact) September is Gynecologic…...